| Title |
Fibrinolytic agents for peripheral arterial occlusion
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2013
|
| DOI | 10.1002/14651858.cd001099.pub3 |
| Pubmed ID | |
| Authors |
Iain Robertson, David O Kessel, David C Berridge |
| Abstract |
Peripheral arterial thrombolysis is used in the management of peripheral arterial ischaemia. Streptokinase was originally used but safety concerns led to a search for other agents. Urokinase and recombinant tissue plasminogen activator (rt-PA) have increasingly become established as first line agents for peripheral arterial thrombolysis. Potential advantages of these agents include improved safety, greater efficacy and a more rapid response. Recently drugs such as pro-urokinase, recombinant staphylokinase and alfimperase have been introduced. This is an update of a review first published in 2010. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ireland | 1 | 50% |
| United Kingdom | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
| Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 120 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 14 | 12% |
| Student > Bachelor | 14 | 12% |
| Student > Postgraduate | 11 | 9% |
| Researcher | 9 | 8% |
| Student > Ph. D. Student | 9 | 8% |
| Other | 26 | 22% |
| Unknown | 37 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 56 | 47% |
| Nursing and Health Professions | 11 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Unspecified | 3 | 3% |
| Neuroscience | 2 | 2% |
| Other | 12 | 10% |
| Unknown | 33 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2014.
All research outputs
#20,011,485
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,818
of 11,499 outputs
Outputs of similar age
#236,042
of 320,902 outputs
Outputs of similar age from Cochrane database of systematic reviews
#212
of 221 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,902 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 221 others from the same source and published within six weeks on either side of this one. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.